ArticleVirologica Sinica2025
Eltrombopag, an FDA-approved drug, inhibits dengue virus type 2 by targeting NS2B-NS3 protease.
Xuerui Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleVirologica Sinica2025
Xuerui Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.